Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
45,466,239
-
Shares change
-
+255,056
-
Total reported value, excl. options
-
$566,540,993
-
Value change
-
+$4,511,593
-
Put/Call ratio
-
52%
-
Number of buys
-
40
-
Number of sells
-
36
-
Price
-
$12.46
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2019
As of 31 Mar 2019 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,466,239 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, OppenheimerFunds, Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Redmile Group, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and JENNISON ASSOCIATES LLC.
This table shows 76 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.